Feb 6 | News
DEERFIELD, Ill., October 15, 2009 – Baxter International Inc. (NYSE:BAX) today reported solid financial results for the third quarter of 2009, and provided its fourth quarter and updated full-year 2009 financial outlook.
|
Feb 6 | News
Pediatric patients, parents and caregivers discuss the benefits of Hylenex for use in pediatric rehydration. Click here to see the video.
|
Feb 6 | News
DEERFIELD, Ill., October 30, 2009 – Baxter Healthcare Corporation today announced the launch of the Education Advantage program, an innovative scholarship program to promote career development and encourage proactive health management and community involvement among people with...
|
Jan 30 | News
In the area surrounding the rural, blue collar town of Windsor, Vt, the statistics weren't encouraging. Fifty-four percent of children in the local elementary school came from families with incomes below 110 percent of the poverty rate. Per capita income averaged $21,936. Community health...
|
Jan 30 | News
DEERFIELD, Ill., January 30, 2012 - Baxter International Inc. (NYSE:BAX) announced today that the U.S. Food and Drug Administration (FDA) has approved TISSEEL [Fibrin Sealant] to include general hemostasis in surgery when control of bleeding by standard surgical techniques is ineffective...
|
Jan 26 | News
Baxter has again been recognized as one of the "Global 100 Most Sustainable Corporations" by Corporate Knights Inc., an independent Canadian-based media company focused on sustainable development. The list is announced each year during the World Economic Forum in Davos,...
|
Jan 26 | News
Company Achieves Record Sales and Earnings in 2011
|
Jan 24 | News
CHICAGO, January 24, 2012 - In honor of its broad-based efforts to improve the lives of the most vulnerable members of its community, Mt. Ascutney Hospital and Health Center (MAHHC) in Windsor, Vt., is the recipient of the 2011 Foster G. McGaw Prize for Excellence in Community Service,...
|
Jan 23 | News
DEERFIELD, Ill., January 23, 2012 - Baxter International Inc. (NYSE:BAX) today provided an update on its clinical program evaluating the use of its GAMMAGARD LIQUID 10% [Immune Globulin Infusion (Human)] (marketed as KIOVIG outside the United States and Canada), for the treatment of mild...
|
Jan 9 | News
DEERFIELD, Ill., January 9, 2012 - Baxter International Inc. (NYSE:BAX) announced today that Jean-Luc Butel has been appointed corporate vice president and president, international, reporting to Robert L. Parkinson, Jr., chairman and chief executive officer. He will assume his new role on...
|